CASE STUDY Successes in Phase II Autologous Cellular Therapy Oncology Program Implementing logistics management, site startup, and clinical quality management in two autologous adoptive cellular therapy oncology studies.Successes in Phase II Autologous Cellular Therapy Oncology Program Implementing logistics management, site startup, and clinical quality management in two autologous adoptive cellular therapy oncology studies. Endpoints of Interest Response and disease control efficacy, as assessed by the IRC per RECIST v1.1 and irRECIST Indication Solid tumors Study Phase Phase II Business Segment Product Registration Services Drug Class Autologous Adoptive Cellular Therapy PRA Services Project Management Vendor Management Clinical Operations Logistics Management Regula

Join for free to read